Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e2390d41464cdfec4901b0b4f543136 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1658 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
filingDate |
2014-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af04d5326b6abccf1bf02b9b12ce5d02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b64cc3b49aae7352708087b744c3bf8f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f08d7264f7b09edfe137e5b5debf8bab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_440beaf1517f24e33fd97da9818f064b |
publicationDate |
2015-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20150131435-A |
titleOfInvention |
Compositions for TACE comprising the first and second biodegradable microbeads and Methods for preparing thereof |
abstract |
The present invention provides a chemical-exclusive composition comprising two kinds of biodegradable micro-beads having different anticancer drug release characteristics and a method for producing the same. According to the present invention, by controlling the compounding ratio of the first and second biodegradable microbeads, it is possible to efficiently produce a composition dedicated to chemical color that exhibits desired anticancer drug release characteristics. Therefore, the present invention can be utilized for chemoembolization of liver cancer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018062865-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180034289-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11617723-B2 |
priorityDate |
2014-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |